Agrawal V - Search Results

1

Effects of genetic variants of human P450 oxidoreductase on catalysis by CYP2D6 in vitro.

Sandee D, Morrissey K, Agrawal V, Tam HK, Kramer MA, Tracy TS, Giacomini KM, Miller WL. Sandee D, et al. Among authors: agrawal v. Pharmacogenet Genomics. 2010 Nov;20(11):677-86. doi: 10.1097/FPC.0b013e32833f4f9b. Pharmacogenet Genomics. 2010. PMID: 20940534 Free PMC article.

2

P450 oxidoreductase deficiency: a new disorder of steroidogenesis.

Miller WL, Huang N, Pandey AV, Flück CE, Agrawal V. Miller WL, et al. Among authors: agrawal v. Ann N Y Acad Sci. 2005 Dec;1061:100-8. doi: 10.1196/annals.1336.012. Ann N Y Acad Sci. 2005. PMID: 16467261 Review.

3

Genetics of P450 oxidoreductase: sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutations.

Huang N, Agrawal V, Giacomini KM, Miller WL. Huang N, et al. Among authors: agrawal v. Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1733-8. doi: 10.1073/pnas.0711621105. Epub 2008 Jan 29. Proc Natl Acad Sci U S A. 2008. PMID: 18230729 Free PMC article.

4

The common P450 oxidoreductase variant A503V is not a modifier gene for 21-hydroxylase deficiency.

Gomes LG, Huang N, Agrawal V, Mendonça BB, Bachega TA, Miller WL. Gomes LG, et al. Among authors: agrawal v. J Clin Endocrinol Metab. 2008 Jul;93(7):2913-6. doi: 10.1210/jc.2008-0304. Epub 2008 Apr 8. J Clin Endocrinol Metab. 2008. PMID: 18397975 Free PMC article.

5

Pharmacogenetics of P450 oxidoreductase: effect of sequence variants on activities of CYP1A2 and CYP2C19.

Agrawal V, Huang N, Miller WL. Agrawal V, et al. Pharmacogenet Genomics. 2008 Jul;18(7):569-76. doi: 10.1097/FPC.0b013e32830054ac. Pharmacogenet Genomics. 2008. PMID: 18551037

6

Genetic variation in human P450 oxidoreductase.

Miller WL, Huang N, Agrawal V, Giacomini KM. Miller WL, et al. Among authors: agrawal v. Mol Cell Endocrinol. 2009 Mar 5;300(1-2):180-4. doi: 10.1016/j.mce.2008.09.017. Epub 2008 Sep 26. Mol Cell Endocrinol. 2009. PMID: 18930113 Review.

7

Clinical, genetic, and enzymatic characterization of P450 oxidoreductase deficiency in four patients.

Sahakitrungruang T, Huang N, Tee MK, Agrawal V, Russell WE, Crock P, Murphy N, Migeon CJ, Miller WL. Sahakitrungruang T, et al. Among authors: agrawal v. J Clin Endocrinol Metab. 2009 Dec;94(12):4992-5000. doi: 10.1210/jc.2009-1460. Epub 2009 Oct 16. J Clin Endocrinol Metab. 2009. PMID: 19837910 Free PMC article.

8

Substrate-specific modulation of CYP3A4 activity by genetic variants of cytochrome P450 oxidoreductase.

Agrawal V, Choi JH, Giacomini KM, Miller WL. Agrawal V, et al. Pharmacogenet Genomics. 2010 Oct;20(10):611-8. doi: 10.1097/FPC.0b013e32833e0cb5. Pharmacogenet Genomics. 2010. PMID: 20697309 Free PMC article.

9

Consequences of POR mutations and polymorphisms.

Miller WL, Agrawal V, Sandee D, Tee MK, Huang N, Choi JH, Morrissey K, Giacomini KM. Miller WL, et al. Among authors: agrawal v. Mol Cell Endocrinol. 2011 Apr 10;336(1-2):174-9. doi: 10.1016/j.mce.2010.10.022. Epub 2010 Nov 9. Mol Cell Endocrinol. 2011. PMID: 21070833 Free PMC article.

10

Effect of P450 oxidoreductase variants on the metabolism of model substrates mediated by CYP2C9.1, CYP2C9.2, and CYP2C9.3.

Subramanian M, Agrawal V, Sandee D, Tam HK, Miller WL, Tracy TS. Subramanian M, et al. Among authors: agrawal v. Pharmacogenet Genomics. 2012 Aug;22(8):590-7. doi: 10.1097/FPC.0b013e3283544062. Pharmacogenet Genomics. 2012. PMID: 22547083

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,125 results

Search Page

Filters